Cargando…
Notch3 and Hey-1 as Prognostic Biomarkers in Pancreatic Adenocarcinoma
In order to achieve a better outcome for pancreatic cancer patients, reliable biomarkers are required which allow for improved diagnosis. These may emanate from a more detailed molecular understanding of the aggressive nature of this disease. Having previously reported that Notch3 activation appeare...
Autores principales: | Mann, Christopher D., Bastianpillai, Christopher, Neal, Christopher P., Masood, Muhammad M., Jones, Donald J. L., Teichert, Friederike, Singh, Rajinder, Karpova, Elena, Berry, David P., Manson, Margaret M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3514220/ https://www.ncbi.nlm.nih.gov/pubmed/23226563 http://dx.doi.org/10.1371/journal.pone.0051119 |
Ejemplares similares
-
Serum Induces Transcription of Hey1 and Hey2 Genes by Alk1 but Not Notch Signaling in Endothelial Cells
por: Wöltje, Kerstin, et al.
Publicado: (2015) -
Nuclear Factor I Represses the Notch Effector HEY1 in Glioblastoma()
por: Brun, Miranda, et al.
Publicado: (2018) -
Physiological Notch Signaling Maintains Bone Homeostasis via RBPjk and Hey Upstream of NFATc1
por: Tu, Xiaolin, et al.
Publicado: (2012) -
Delta–Notch—and then? Protein interactions and proposed modes of repression by Hes and Hey bHLH factors
por: Fischer, Andreas, et al.
Publicado: (2007) -
The Anti-Adipogenic Potential of COUP-TFII Is Mediated by Downregulation of the Notch Target Gene Hey1
por: Scroyen, Ilse, et al.
Publicado: (2015)